Barclays Lowers Definitive Healthcare (NASDAQ:DH) Price Target to $3.00
Definitive Healthcare (NASDAQ:DH – Free Report) had its price target trimmed by Barclays from $4.00 to $3.00 in a research note released on Monday,Benzinga reports. They currently have an underweight rating on the stock. Several other research analysts have also weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares […]
Definitive Healthcare (NASDAQ:DH – Free Report) had its price target trimmed by Barclays from $4.00 to $3.00 in a research note released on Monday,Benzinga reports. They currently have an underweight rating on the stock. Several other research analysts have also weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares […]
